Inovio Pharmaceuticals Inc

NASDAQ:INO  
6.18
-0.43 (-6.50%)
4:13:06 PM EDT: $6.20 +0.02 (+0.32%)
Products

Inovio Receives FDA Authorization To Proceed With Phase 3 Of Its COVID-19 Vaccine Candidate

Published: 11/09/2021 13:14 GMT
Inovio Pharmaceuticals Inc (INO) - Inovio Receives U.S. FDA Authorization to Proceed With Innovate Phase 3 Segment for Its Covid-19 Vaccine Candidate, Ino-4800, in the U.S.inovio Pharmaceuticals Inc - FDA Lifts Partial Clinical Hold on Innovate Phase 3 Segment.
Inovio - FDA Has Lifted Partial Clinical Hold Following FDA's Review of Additional Non-clinical, Clinical, and Device Information Provided by Inovio.
Inovio- Partnering With Advaccine Biopharmaceuticals Suzhou Co Ltd to Conduct Innovate Phase 3 Segment in Multiple Countries in Americas, Asia, Africa.